EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhancing therapeutic potential: Human adipose‐derived mesenchymal stem cells modified with recombinant adeno‐associated virus expressing VEGF165 gene for peripheral nerve injury

Shuai Jiang iD, Bo Chen iD, Zhen-Yu Sun

The Kaohsiung Journal of Medical Sciences · 2024

DOI: 10.1002/kjm2.12875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2024. Verfasst von Shuai Jiang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China. Hauptthemen laut MEDLINE: Dependovirus, Vascular Endothelial Growth Factor A, Mesenchymal Stem Cells, Peripheral Nerve Injuries. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Laboratory of Hand Reconstruction of Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to investigate the therapeutic potential of human adipose‐derived mesenchymal stem cells (hADSCs) modified with recombinant adeno‐associated virus (rAAV) carrying the vascular endothelial growth factor 165 (VEGF165) gene in peripheral nerve injury (PNI). The hADSCs were categorized into blank, control (transduced with rAAV control vector), and VEGF165 (transduced with rAAV VEGF165 vector) groups. Subsequently, Schwann cell differentiation was induced, and Schwann cell markers were assessed. The sciatic nerve injury mouse model received injections of phosphate‐buffered saline (PBS group), PBS containing hADSCs (hADSCs group), rAAV control vector (control‐hADSCs group), or rAAV VEGF165 vector (VEGF165‐hADSCs group) into the nerve defect site. Motor function recovery, evaluated through the sciatic function index (SFI), and nerve regeneration, assessed via toluidine blue staining along with scrutiny of Schwann cell markers and neurotrophic factors, were conducted. Modified hADSCs exhibited enhanced Schwann cell differentiation and elevated expression of Schwann cell markers [S100 calcium‐binding protein B (S100B), NGF receptor (NGFR), and glial fibrillary acidic protein (GFAP)]. Mice in the VEGF165‐hADSCs group demonstrated improved motor function recovery compared to those in the other three groups, accompanied by increased fiber diameter, axon diameter, and myelin thickness, as well as elevated expression of Schwann cell markers (S100B, NGFR, and GFAP) and neurotrophic factors [mature brain‐derived neurotrophic factor (BDNF) and glial cell‐derived neurotrophic factor (GDNF)] in the distal nerve segment. rAAV‐VEGF165 modification enhances hADSC potential in PNI, promoting motor recovery and nerve regeneration. Elevated Schwann cell markers and neurotrophic factors underscore therapy benefits, providing insights for nerve injury strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusVascular Endothelial Growth Factor AMesenchymal Stem CellsPeripheral Nerve InjuriesSchwann CellsMesenchymal Stem Cell TransplantationCell DifferentiationHumansAnimalsMiceNerve RegenerationAdipose TissueGenetic VectorsSciatic NerveMale

Stichwörter der Autor:innen

mesenchymal stem cellsnervous system diseasesperipheral nerve injuriesrecombinant adeno‐associated virusesvascular endothelial growth factor A

Substanzen

Vascular Endothelial Growth Factor AVEGFA protein, human

Autor:innen und Institutionen

  • Department of Orthopedics, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, Hangzhou, China.

ORCID-Profile: Shuai Jiang, Bo Chen

Förderung

  • Key Laboratory of Hand Reconstruction of Ministry of Health

Zitieren

APA

Jiang, S., Chen, B., & Sun, Z. Y. (2024). Enhancing therapeutic potential: Human adipose‐derived mesenchymal stem cells modified with recombinant adeno‐associated virus expressing VEGF165 gene for peripheral nerve injury. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.12875

Vancouver

Jiang S, Chen B, Sun ZY. Enhancing therapeutic potential: Human adipose‐derived mesenchymal stem cells modified with recombinant adeno‐associated virus expressing VEGF165 gene for peripheral nerve injury. The Kaohsiung Journal of Medical Sciences. 2024. doi:10.1002/kjm2.12875

BibTeX
@article{Jiang2024,
  author = {Jiang, Shuai and Chen, Bo and Sun, Zhen-Yu},
  title = {Enhancing therapeutic potential: Human adipose‐derived mesenchymal stem cells modified with recombinant adeno‐associated virus expressing VEGF165 gene for peripheral nerve injury},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2024},
  doi = {10.1002/kjm2.12875}
}
Kostenlos starten →